Lucence
Singapore, SG · Founded 2016 · 105 employees on LinkedIn · 3 known investors
Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.
Investors · 3
In the news
Frequently asked questions
- What does Lucence do?
- Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.
- Who are Lucence's investors?
- Lucence's investors include Openspace Ventures, Heliconia Capital, SGInnovate.
- Where is Lucence headquartered?
- Lucence is headquartered in Singapore, SG.